Drugs / anti-mycoplasma hominis antibodies
anti-mycoplasma hominis antibodies
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02508584 | Apr 2016 → Jun 2019 | B cell deficiency, bacterial arthritis | Brigham and Women's Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | anti-mycoplasma hominis antibodies | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02508584 ↗ |
| Modality | Protein / enzyme biologic | “then administer the purified human IgG to M. A.” NCT02508584 ↗ |